ATE131071T1 - Leukozyten-adhäsions-inhibitor. - Google Patents

Leukozyten-adhäsions-inhibitor.

Info

Publication number
ATE131071T1
ATE131071T1 AT89910339T AT89910339T ATE131071T1 AT E131071 T1 ATE131071 T1 AT E131071T1 AT 89910339 T AT89910339 T AT 89910339T AT 89910339 T AT89910339 T AT 89910339T AT E131071 T1 ATE131071 T1 AT E131071T1
Authority
AT
Austria
Prior art keywords
leukocyte adhesion
adhesion inhibitor
endothelial cells
endothelial
inflammation
Prior art date
Application number
AT89910339T
Other languages
English (en)
Inventor
Michael A Gimbrone Jr
Margaret Elyse Wheeler
Original Assignee
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham & Womens Hospital filed Critical Brigham & Womens Hospital
Application granted granted Critical
Publication of ATE131071T1 publication Critical patent/ATE131071T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5421—IL-8
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT89910339T 1988-08-15 1989-08-15 Leukozyten-adhäsions-inhibitor. ATE131071T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23222488A 1988-08-15 1988-08-15

Publications (1)

Publication Number Publication Date
ATE131071T1 true ATE131071T1 (de) 1995-12-15

Family

ID=22872317

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89910339T ATE131071T1 (de) 1988-08-15 1989-08-15 Leukozyten-adhäsions-inhibitor.

Country Status (6)

Country Link
US (1) US5302384A (de)
EP (1) EP0429542B1 (de)
JP (1) JPH04500076A (de)
AT (1) ATE131071T1 (de)
DE (1) DE68925032T2 (de)
WO (1) WO1990001338A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH680001A5 (de) 1987-11-19 1992-05-29 Sandoz Ag
JPH05503512A (ja) * 1989-11-29 1993-06-10 ブリガム・アンド・ウイメンズ・ホスピタル 白血球接着阻害因子としての［ａｌａ　ｉｌ―８］↓７↓７
JPH05505391A (ja) * 1989-11-29 1993-08-12 ブリガム・アンド・ウイメンズ・ホスピタル 内皮由来のｉｌ―８
EP0616615B1 (de) * 1991-12-04 1998-08-12 The Biomedical Research Centre Limited Analoge des menschlichen Interleukin-8.
US7135458B1 (en) * 1995-11-15 2006-11-14 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use
US5811073A (en) * 1995-06-19 1998-09-22 President And Fellows Of Harvard College Method for radioisotopic detection and localization of inflammation in a host
DE19548630A1 (de) * 1995-12-12 1997-06-19 Schering Ag Verfahren zur Reinigung von rekombinantem Human-Interleukin - 8
US7067117B1 (en) 1997-09-11 2006-06-27 Cambridge University Technical Services, Ltd. Compounds and methods to inhibit or augment an inflammatory response
US6989435B2 (en) 1997-09-11 2006-01-24 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
US7238711B1 (en) 1999-03-17 2007-07-03 Cambridge University Technical Services Ltd. Compounds and methods to inhibit or augment an inflammatory response
DE10003811A1 (de) * 2000-01-28 2001-08-09 Sanorell Pharma Gmbh & Co Verfahren zur Herstellung eines serumhaltigen Kulturmediums für Zellen sowie dessen Verwendung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5729949A (en) * 1980-07-30 1982-02-18 Nippon Koutai Kenkyusho:Kk Determination of sugar branch related to cancer and diagnostic technique of cancer
US4897348A (en) * 1983-08-25 1990-01-30 Sri International Recombinant materials and methods for producing human connective tissue-activating peptide-III and analogs thereof
DE3854536T2 (de) * 1987-05-04 1996-03-07 Dana Farber Cancer Inst Inc Interzellulare Adhäsions-Moleküle und deren Bindungsliganden.
US4840793A (en) * 1987-06-11 1989-06-20 Dana-Farber Cancer Institute Method of reducing tissue damage at an inflammatory site using a monoclonal antibody
US4797277A (en) * 1987-09-22 1989-01-10 Pharmacia Ab Method for reperfusion therapy
CH680001A5 (de) * 1987-11-19 1992-05-29 Sandoz Ag

Also Published As

Publication number Publication date
DE68925032T2 (de) 1996-04-25
EP0429542B1 (de) 1995-12-06
JPH04500076A (ja) 1992-01-09
US5302384A (en) 1994-04-12
EP0429542A1 (de) 1991-06-05
EP0429542A4 (en) 1991-12-11
WO1990001338A1 (en) 1990-02-22
DE68925032D1 (de) 1996-01-18

Similar Documents

Publication Publication Date Title
ATE131071T1 (de) Leukozyten-adhäsions-inhibitor.
DE69517196T2 (de) Inhibitoren der menschlichen neutrophilenelastase
ATE140968T1 (de) Kultur des wachstumsfaktors der vaskularen endothelialzellen und dns, die dafür kodiert
DE68910627T2 (de) Gasphasen-Alpha-Olefinpolymerisationsverfahren in Anwesenheit eines Aktivitätshemmers.
ATE249421T1 (de) Inhibitoren der alpha4-beta1 vermittelten zelladhäsion
MY104685A (en) Substituted thiazoles and their use as fungicides.
DK0489837T4 (da) Inhibering af lymfocytters adhæsion til vaskulært endotel under anvendelse af en hidtil ukendt interaktion mellem ekstracellulær matrixreceptor og ligand
WO1992015605A3 (en) Inhibitors of human neutrophil elastase and human cathepsin g
AP9100310A0 (en) Tnf inhibitors
DK0402068T3 (da) Polypeptider og polypeptidanaloger med inhiberende virkning mod human elastase
ES2136091T3 (es) Inhibidores de catepsina g y elastasa para prevenir la degradacion del tejido conectivo.
FR2643557B1 (fr) Utilisation de n-acylcysteines dans le traitement de maladies associees aux infections par hiv
DK0830130T3 (da) TNF-alfa-omdannende enzym
FI935780A (fi) HIV-proteaasin inhibiittoreita, jotka ovat hyödyllisiä AIDSin hoitoa varten
FI943357A (fi) Puheen lomitussyvyyden suurentaminen yhdessä lyhennetyn viiveen kanssa
ES2168095T3 (es) Inhibidores de neutrofilos procedentes de nematodos.
ATE182890T1 (de) 3-alkyloxy-, aryloxy-, oder arylalkyloxy- benzo(b>thiophen- 2-carboxamide als inhibitoren von zelladhäsion
DE69021128D1 (de) Interleukin-1-Inhibitor.
DK0862454T3 (da) CTLA-8 i kombination med G-CSF eller med G-CSF og IL-6 og anvendelse af CTLA-8 til behandling af infektioner
ATE233570T1 (de) Verwendung des leukämie-inhibitor-faktor und endothelin antagonisten
IT1241921B (it) Perfezionamenti relativi alla rivelazione di scariche ad arco in cavi.
DE69332904D1 (de) Hemmung von hiv-infektion
FR2698270B1 (fr) Utilisation du 5-méthoxypsoralène dans le traitement du sida.
DE69227089T2 (de) Weizen Alpha-Amylase-Inhibitor zur Behandlung von Diabetes
FI982503A0 (fi) C3-C3-polyfluorialkaanien käyttö ponnekaasuina suihkuttimissa

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee